Trimble Inc. (NASDAQ:TRMB – Free Report) – Stock analysts at William Blair reduced their Q1 2025 earnings per share (EPS) estimates for shares of Trimble in a report issued on Wednesday, February 19th ...

Equities research analysts at William Blair reduced their Q1 2025 earnings per share (EPS) estimates for shares of Pool in a report issued on Thursday, February 20th. William Blair analyst R. Merkel ...

Commerce Secretary Howard Lutnick singled out the industry, alleging its use of foreign-flagged vessels lets companies avoid ...

Fintel reports that on February 21, 2025, William Blair downgraded their outlook for CACI International (NYSE:CACI) from ...

Merck’s Keytruda may be the most talked about drug facing loss of exclusivity but it’s far from the only one, as several of ...

Non-opioid pain therapies are entering an unprecedented era, marked by the landmark FDA approval of Vertex’s Journavx and a ...

In a report released today, Andy Hsieh from William Blair maintained a Buy rating on Cardiff Oncology (CRDF – Research Report). The company’s ...

William Blair downgraded Booz Allen (BAH) to Market Perform from Outperform.Discover the Best Stocks and Maximize Your Portfolio: See what ...

Fintel reports that on February 21, 2025, William Blair downgraded their outlook for General Dynamics (WBAG:GEDY) from Outperform to Market Perform. There are 2,727 funds or institutions reporting ...

Charles River Laboratories International Inc (NYSE:CRL) reported fourth-quarter 2024 revenue of $1 billion, a decrease of 1.1 ...

Pediatrix Medical reported Q4 revenue of $502.36 million, surpassing estimates, with adjusted EPS of $0.51. The company ...

Repligen Corp (NASDAQ:RGEN) released its fourth-quarter adjusted EPS of 44 cents on Tuesday, down from 48 cents a year ago ...